Microrna In Disease Regulation
60 researchers across 6 institutions
This research area investigates the role of microRNAs (miRNAs) in the development and progression of various diseases. Researchers explore how these small RNA molecules, which regulate gene expression, are altered in conditions such as cancer, cardiovascular disease, metabolic disorders, and neurological conditions. Studies employ molecular biology techniques, genomics, and bioinformatics to identify disease-specific miRNA signatures, elucidate their regulatory mechanisms, and assess their potential as diagnostic biomarkers or therapeutic targets. Investigations also examine how environmental factors and toxicological exposures, studied at the National Center for Toxicological Research, may influence miRNA expression and contribute to disease.
The study of microRNAs holds significant relevance for Arkansas. Understanding miRNA dysregulation in common health issues like cancer and cardiovascular disease can inform public health initiatives and the development of new diagnostic tools and treatments for the state's population. Furthermore, research into environmental toxicology and its impact on miRNA function aligns with Arkansas's agricultural and natural resource sectors, potentially revealing links between environmental exposures and disease risk. This work can contribute to the state's growing biosciences and health technology industries.
This field draws upon expertise in molecular biology, genetics, pharmacology, and toxicology. Research is conducted across multiple Arkansas institutions, fostering collaboration and a broad base of knowledge in disease mechanisms and molecular regulation.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Robert J. Griffin | UAMS | 71 | 25,813 | Grant PI High Impact | |
| James C. Fuscoe | NCTR | 47 | 13,331 | High Impact | |
| Yong Zhu | UAMS | 41 | 5,408 | Grant PI High Impact | |
| Seong Wook Kang | University of Arkansas | 35 | 4,848 | High Impact | |
| Alexander Burnett | UAMS | 30 | 3,547 | High Impact | |
| Fei Jia | University of Arkansas | 28 | 2,658 | High Impact | |
| Carrie L. Moland | NCTR | 28 | 3,349 | High Impact | |
| Ruby Charak | UAMS | 25 | 2,098 | ||
| Kelly E. Mercer | NCTR | 24 | 3,453 | High Impact | |
| Lu Dai | UAMS | 23 | 1,643 | ||
| Pritmohinder S. Gill | UAMS | 21 | 2,197 | High Impact | |
| Ryan M. Allen | UAMS | 20 | 2,218 | High Impact | |
| Chhanda Bose | UAMS | 20 | 1,078 | High Impact | |
| Valentina K. Todorova | UAMS | 18 | 785 | ||
| Vikrant Vijay | NCTR | 16 | 1,163 | ||
| Syed J. Mehdi | UAMS | 16 | 626 | ||
| Bounleut Phanavanh | NCTR | 16 | 2,025 | ||
| Svitlana Shpyleva | NCTR | 15 | 1,414 | ||
| M. J. Birrer | UAMS | 15 | 1,706 | ||
| Japneet Kaur | UAMS | 14 | 589 | Grants |
Related Research Areas
Connected Research Areas
Topics that share active collaborators with Microrna In Disease Regulation in Arkansas. Pairs are ranked by collaboration density relative to expected co-authorship under a random null. This describes existing connections, not investment recommendations.
- Bacteriophages and microbial interactions
- Cancer-related molecular mechanisms research
- Bacterial Genetics and Biotechnology
- Pharmacological Effects and Toxicity Studies
- Machine Learning Applications
- Molecular Biology Techniques and Applications
- Diet and metabolism studies
- Genomics and Phylogenetic Studies
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 Harvard University 2,529
- 2 The University of Texas MD Anderson Cancer Center 1,673
- 3 The Ohio State University 1,341
- 4 National Institutes of Health 1,174
- 5 Johns Hopkins University 1,147
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Microrna In Disease Regulation.